A comparison of fatigue in two groups of cancer patients administered or not administered carnitine after the cisplatin administration: A non-blinded, randomized controlled study
Not Applicable
- Conditions
- Cancer patients who will receive chemotherapy including cisplatin (The target will be all types of tumors.)
- Registration Number
- JPRN-UMIN000017660
- Lead Sponsor
- Toyama University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Prognosis less than 3 months 2)Hemoglobin < 10g/dL 3)Less than one month after operation or radiotherapy 4)Ineligible judged by physician other than above
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Carnitine concentrations in plasma and urine Fatigue scale (FACIT-F)
- Secondary Outcome Measures
Name Time Method